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Abstract
Background: Iron (Fe) deficiency is the most common micronutrient deficiency worldwide. Iron biofortification is a
preventative strategy that alleviates Fe deficiency by improving the amount of absorbable Fe in crops. In the present
study, we used an in vitro digestion/Caco 2 cell culture model as the guiding tool for breeding and development of two
maize (Zea mays L.) lines with contrasting Fe bioavailability (ie. Low and High). Our objective was to confirm and validate
the in vitro results and approach. Also, to compare the capacities of our two maize hybrid varieties to deliver Fe for
hemoglobin (Hb) synthesis and to improve the Fe status of Fe deficient broiler chickens.
Methods: We compared the Fe-bioavailability between these two maize varieties with the presence or absence of added
Fe in the maize based-diets. Diets were made with 75% (w/w) maize of either low or high Fe-bioavailability maize, with or
without Fe (ferric citrate). Chicks (Gallus gallus) were fed the diets for 6 wk. Hb, liver ferritin and Fe related transporter/
enzyme gene-expression were measured. Hemoglobin maintenance efficiency (HME) and total body Hb Fe values were
used to estimate Fe bioavailability from the diets.
Results: DMT-1, DcytB and ferroportin expressions were higher (P < 0.05) in the "Low Fe" group than in the "High Fe"
group (no added Fe), indicating lower Fe status and adaptation to less Fe-bioavailability. At times, Hb concentrations (d
21,28,35), HME (d 21), Hb-Fe (as from d 14) and liver ferritin were higher in the "High Fe" than in the "Low Fe" groups (P <
0.05), indicating greater Fe absorption from the diet and improved Fe status.
Conclusions: We conclude that the High Fe-bioavailability maize contains more bioavailable Fe than the Low
Fe-bioavailability maize, presumably due to a more favorable matrix for absorption. Maize shows promise for Fe
biofortification; therefore, human trials should be conducted to determine the efficacy of consuming the high
bioavailable Fe maize to reduce Fe deficiency.






Iron (Fe) deficiency affects one-third of the world's
population [1]. Iron is vital for oxygen transport and
energy metabolism [2]. The consequences of Fe deficiency
anemia include impaired growth, retarded psychomotor
and cognitive development, damaged immune mechan-
isms with increased morbidity and mortality rates [1,3].RE
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reproduction in any medium, provided the orEfforts to decrease dietary Fe deficiency utilize fortifi-
cation, supplementation and diversification of diets.
These strategies had limited success in resource-limited
environments and poor countries due to cost, limited
health care, and availability of food processing facilities
[4-7]. Hence, genetic improvement (biofortification) of
staple crops is an attractive alternative to dietary fortifi-
cation or diversification, as delivery of the Fe-rich staple
is achieved through the development and promotion of
new plant varieties that are aimed to alleviate dietary Fe
deficiency and anemia [7].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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countries and provides energy, vitamins and minerals
[8-15]. However, a major cause of Fe deficiency is poor
intake of Fe, due to low bioavailability from plant-based
diets containing mineral absorption inhibitors as poly-
phenols and phytates. In the most maize-dependent
countries, where maize provides ≥ 20% of dietary protein,
Fe deficiency and anemia are prevalent [1,16-18]. Hence,
maize is an attractive candidate for Fe biofortification.
Increased Fe concentration in staple food crops may
not necessarily translate into a proportional increase in
absorbed Fe, because crop varieties with high Fe concen-
trations may have increased (or decreased) concentra-
tions of Fe absorption inhibitors or enhancers. It is
necessary to measure the amount of Fe concentration
and bioavailability in new Fe-enhanced crops. The
in vitro screening employs a simulated gastric and intes-
tinal digestion of food coupled with culture of human
intestinal cells [19]. This bioassay is necessary to pin-
point genetic markers for Fe bioavailability.
Research into the genetic basis for Fe nutritional qual-
ity in maize has established the potential for Fe bioforti-
fication, as Fe concentration and bioavailability are
under genetic control and have demonstrated potential
for improvement [8,9]. Previously, we utilized quantita-
tive trait locus (QTL) mapping to characterize the gen-
etic complexity of Fe concentration and bioavailability in
maize [9,20,21]. New varieties were developed using
members of the mapping population, that were largely
identical except in the chromosomal regions surround-
ing the 3 QTL with largest effect on Fe bioavailability.
These derivatives were selected to create a maximal de-
gree of contrast in predicted Fe bioavailability. With
High and Low varieties in both parental backgrounds,
these High-Fe and Low-Fe bioavailability hybrids are
essentially identical for all parts of their genomes (all
features of grain quality would be expected to be the
same) except the 3 QTL-containing regions on maize
chromosomes 3, 6 and 9 [8,9]. Preliminary in vivo study
indicated that the predictions made with the Caco-2 bio-
assay were valid for predicting Fe bioavailability [8]. The
equivalence of the High-Fe and Low-Fe bioavailability
varieties for grain Fe concentration, flowering time, and
other characteristics except Fe bioavailability suggests
that our strategy of creating these hybrids and the focus
on the effect of the 3 major QTL was successful [8,9].
The poultry model have been used for nutritional re-
search and was shown to be an excellent animal to
model Fe bioavailability, as chicks respond quickly to
malnutrition, and their micronutrient deficient pheno-
types include poor Fe status, growth stunting, and organ
hypertrophy [22-24]. Also, this model agrees well with
human cell line in vitro results [22-25]. Hence, the ob-




TEcapacities of our two new maize hybrid varieties to de-
liver Fe for hemoglobin synthesis and to improve the Fe
status of Fe deficient broiler chickens.
Materials and methods
Creation of high-Fe bioavailability and low-Fe
bioavailability maize varieties
QTL-mapping is the process of utilizing genetically
mapped varieties coupled with a biological measurement
(as Fe bioavailability) and then utilizing statistics to cor-
relate that measurement with genetic markers. QTL-
mapping revealed that Fe concentration in maize grain
was under the control of at least 10 regulatory factors
on 6 of the 10 chromosomes of maize [9]. However, Fe-
bioavailability was regulated by fewer, larger QTL, which
suggested that this trait might be easier to manipulate.
Furthermore, Fe concentration and bioavailability had
only a small positive association between them indicat-
ing that Fe concentration differences between members
of the mapping population were not driving the differ-
ences in Fe bioavailability [9]. Derivation of the High-Fe
and Low-Fe bioavailability maize hybrids was previously
described [8,9]. Briefly, The Caco-2 bioassay was the
guiding tool for the measure of Fe bioavailability in the
maize grain [9]. Statistical analysis was used to identify
molecular markers (i.e. QTL) associated with Fe bio-
availability. These markers were used to select sister
lines that contrasted for the 3 largest effect QTL in
order to create new varieties that were highly genetically
similar but different (high or low) for Fe-bioavailability.
As sister lines were created in both of the parental gen-
etic backgrounds used in the mapping population, nearly
isogenic hybrids were made by crossing the parents lines
(high with high and low with low). These hybrids were
heterozygous everywhere except the 3 Fe-bioavailability
QTL [9] and were similar except for bioavailable-Fe in
the whole grain [8] (Figure 1). The High-Fe and Low-Fe
maize were produced using standard agronomic prac-
tices at the Cornell University Research Farm (Poplar
Ridge, NY) in the summer of 2009. Plots were mechan-
ically planted and harvested. Grain was dried to ~12%
moisture, processed in bulk (~ 800 Kg of each variety),
and stored at 4°C until the feeding study began. In prep-
aration for the in vivo trial, maize grains were thor-
oughly washed in ddH2O prior to cooking and freeze
drying. Maize varieties were ground prior to mixing the
diets.
Animals, diets and study design
One hundred and twenty fertile Cornish cross broiler
eggs were obtained from a commercial hatchery
(Moyer’s Chicks, Quakertown, PA). Eggs were incubated
under optimal conditions at the Cornell University Ani-






Figure 1 Description of maize (Zea mays L.) varieties used in this study.
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ment groups on the basis of body weight, gender and
blood hemoglobin concentration (aimed to ensure equal
distribution between groups, n=10): 1. "High + Fe": 75%
High-Fe bioavailability cooked maize with added Fe based
diet (65 μg/g Fe). 2. "High": 75% High-Fe bioavailability
cooked maize with no Fe added based diet (24 μg/g Fe).
3. "Low + Fe": 75% Low-Fe bioavailability cooked maize
with added Fe based diet (66 μg/g Fe). 4. "Low": 75% Low-
Fe bioavailability cooked maize with no Fe added based
diet (23 μg/g Fe) (Table 1). Cooked/raw maize were
compared as in vitro pilot studies indicated that cook-
ing may increase the difference in Fe bioavailability
between the two lines. Chicks were housed in a total-
confinement building (1 chick per 0.5 m2 cage). Birds
were under indoor controlled temperatures and were
provided 16 h of light. Cages were equipped with an
automatic nipple drinker and manual self feeder. All
birds were given ad libitum access to water (Fe concen-
tration was 0.379±0.012 μg/g). Iron concentrations in
the water and diets were determined by an inductively-
coupled argon-plasma/atomic emission spectrophotom-
eter (ICAP 61E Thermal Jarrell Ash Trace Analyzer,
Jarrell Ash Co. Franklin, MA) following wet ashing.
Feed intakes were measured daily (from day 1). Iron
intakes were calculated from feed intakes and Fe con-
centration in the diets.
Blood analysis and hemoglobin (Hb) measurements
Blood samples were collected from the wing vein
(n=10,~100 μL) using micro-hematocrit heparinized capil-
lary tubesa (Fisher, Pittsburgh, PA). Samples were collected
following an 8 h overnight feed deprivation. Samples were
analyzed for Hb concentration (see below). Body weights
(BW) and Hb concentrations were measured weekly.
Fe-bioavailability was calculated as hemoglobin main-
tenance efficiency (HME) [23-29]:
HME ¼ HbFe; mg finalð Þ  HbFe; mg initialð Þ
TotalFeIntake;mg
 100
Where Hb-Fe (index of Fe absorption) = total body
hemoglobin Fe. Hb-Fe was calculated from hemoglobin
concentrations and estimates of blood volume based on
BW (a blood volume of 85 mL per kg body weight is
assumed) [23-25,28]:
Hb Fe mgð Þ ¼ BW kgð Þ  0:085 L blood=kg
Hb g=Lð Þ  3:35mg Fe=g Hb:
Fe intakes were calculated from feed intake data and
Fe concentrations in the feed.
Blood Hb concentrations were determined spectro-




TE(H7506-STD, Pointe Scientific Inc. Canton, MI) follow-
ing the kit manufacturer’s instructions.
At the end of the experiment (day 42), birds were
euthanized by carbon-dioxide exposure. The digestive
tracts and livers were quickly removed and separated.
Tissue samples were taken from the small intestine and
liver (~ 1–2 cm; ~2-3 g, respectively). The samples were
immediately frozen in liquid nitrogen, and then stored
in a -80°C freezer until analysis.
All animal protocols were approved by the Cornell
University Institutional Animal Care and Use Committee.
Isolation of total RNA
Total RNA was extracted from 30 mg of the proximal
duodenal tissue (n=10) using Qiagen RNeasy Mini Kit
(RNeasy Mini Kit, Qiagen Inc.,Valencia, CA) according
to the manufacturer’s protocol. Total RNA was eluted in
50 μL of RNase free water. All steps were carried out
under RNase free conditions. RNA was quantified by
absorbance at A260/280. Integrity of the 28S and 18S ribo-
somal RNAs was verified by 1.5% agarose gel electro-
phoresis followed by ethidium-bromide staining. DNA
contamination was removed using TURBO DNase treat-
ment and removal kit from AMBION (Austin, TX,
USA).
DMT1, DcytB and ferroprtin gene expression analysis
As previously described [23-25,27,30], Divalent metal
transporter-1 (DMT1); Duodenal cytochrome-B (DcytB)
and Ferroprtin mRNA levels in duodenal mucosa were
analyzed by quantitative real-time RT-PCR (20 μL reac-
tions); values were normalized to 18S expression. The
total RNA was reverse-transcribed to complementary
DNA in a 25 μL volume containing 1 μg of extracted
RNA. Reverse-transcription was carried out using the
Superscript-First Strand Synthesis Kit for reverse-
transcription PCR according to the manufacturer’s proto-
col (Invitrogen, Carlsbad, CA). Gene-specific primers were
designed using Primer Express software (Applied Biosys-
tems, Carlsbad, CA) chosen from the fragment of the
chicken (Gallus gallus) duodenal DMT1 gene (GeneBank
database; GI 206597489) (forward: 5’-AGC CGT TCA
CCA CTTATT TCG-3’; reverse: 5’-GGT CCA AATAGG
CGA TGC TC-3’), DcytB gene (GI 20380692) (forward:
5’-GGC CGT GTT TGA GAA CCA CAA TGT T-3’; re-
verse: 5’-CGT TTG CAATCA CGT TTC CAA AGAT-3’)
and Ferroportin gene (GI 61098365) (forward: 5’-GAT
GCA TTC TGA ACA ACC AAG GA’; reverse: 5’-GGA
GAC TGG GTG GAC AAG AAC TC-3’). Ribosomal 18S
was used to normalize the results (GI 7262899) (forward:
5’- CGA TGC TCT TAA CTG AGT-3’; reverse: 5’-CAG
CTT TGC AAC CAT ACT C-3’). Real-time PCR was
performed in a 7500 Real-Time PCR system instrument
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Master Mix (Applied Biosystem, Carlsbad, CA), 5 μL of
water, and 1 μL of each primer that was added to 3 μL of
the cDNA diluted 1:25. All reactions were performed in
duplicates and under the following conditions: 50°C for 2
min, 95°C for 2 min, 42 cycles of 95°C for 30 s, and 60°C
for 1 min. Also, to ensure amplification of a single prod-
uct, a dissociation curve was determined under the fol-
lowing conditions: 95°C for 1 min, 55°C for 30 s, and 95°
C for 30 s. Specificity of the product was also confirmed
by running samples on a 1.5% agarose gel, excising for puri-
fication using the QIAquick Gel Extraction Kit (QIAGEN,
Valencia, CA). Calculations of threshold cycles, amplification
efficiencies, and R0 values (the starting fluorescence
value that is proportional to the relative starting tem-
plate concentration) were performed using the data
analysis for real-time PCR Excel workbook and as pre-
viously described [31].
Ferritin and Fe in the liver
We followed previously described procedures [23,24,32,33].
Briefly, 1 g of sample was diluted into 1 mL of 50 mM
Hepes buffer, pH 7.4, and homogenized on ice for 2 min
(5000 g). One mL of each homogenate was subjected to
heat treatment for 10 min at 75°C to aid isolation of fer-
ritin (other proteins are not stable at that temperature).
Subsequently, samples were immediately cooled down on
ice for 30 min. Thereafter, samples were centrifuged for
30 min (13000 g) at 4°C until a clear supernatant was
obtained and the pellet containing most of the insoluble
denaturated proteins was discarded. Iron concentrations
E
Table 1 Composition of experimental diets
Ingredient "High+Fe" Diet
g/Kg diet (by formulation)
High-Fe bioavailability Maize (21 μg Fe/g) 750
Low-Fe bioavailability Maize (20 μg Fe/g) -





Vit/Min1 (no Fe) 70
Ferric citrate 0.25
Total 1000
Concentrations of selected components means±SEM, n=10 (by analysis)4
Fe, μgFe/g diet2 65.3±0.9a
Phytate, μmol/g diet3 10.2 ± 0.2a
1Vitamin and mineral premix provided/kg diet (330002 Chick vitamin mixture; 2300
2Dietary iron concentrations analysis is described in the materials and methods sec
3Method for determining phytate contents are described in the materials and meth




Tin the liver samples were determined by an inductively-
coupled argon-plasma/atomic emission spectrophotom-
eter (ICAP 61E Thermal Jarrell Ash Trace Analyzer, Jarrell
Ash Co. Franklin, MA) following wet ashing.
Electrophoresis, staining and measurement of gels
Native polyacrylamide gel electrophoresis was conducted
using a 6% separating gel and a 5% stacking gel. Samples
were run at a constant voltage of 100 V. Thereafter, gels
were treated with either of the two stains: Coomasie blue
G-250 stain, specific for proteins, or potassium ferricyanide
(K3Fe(CN)6) stain, specific for Fe. The corresponding band
found in the protein and Fe stained gel was considered to
be ferritin [23,24,32,33].
Measurements of the bands were conducted using the
Quantity-One-1-D analysis program (Bio-Rad, Hercules,
CA). The local background was subtracted from each
sample. Horse spleen ferritin (Sigma Aldrich Co., St.
Louis, MO) was used as a standard for calibrating
ferritin protein and Fe concentrations of the samples.
Dilutions of the horse spleen ferritin were made and
treated similarly to the liver supernatant samples in
order to create a reference line for both protein and Fe-
stained gels [23,24,32,33].
In-vitro iron bioavailability assessment
An in vitro digestion/Caco-2 cell culture model
[19,23-28,34,35] was used to assess Fe-bioavailability. The
maize only samples (High- Fe bioavailability maize; Low-Fe
bioavailability maize and control-commercial maize) and

















10.1 ±0.2a 10.1 ± 0.2a 10.0 ±0.2a
00 Salt mix for chick diet; Dyets Inc. Bethlehem, PA).
tion.
ods section.
icantly different, P < 0.05.
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digestion. Briefly, the intestinal digestion is carried out in
cylindrical inserts closed on the bottom by a semiperme-
able membrane and placed in wells containing Caco-2 cell
monolayers bathed in culture medium. The upper chamber
was formed by fitting the bottom of Transwell insert ring
(Corning) with a 15000 Da molecular weight cut off
(MWCO) membrane (Spectra/Por 2.1, Spectrum Medical,
Gardena, CA). The dialysis membrane was held in place
using a silicone ring (Web Seal, Rochester, NY).
Iron uptake by the Caco-2 cell monolayers was
assessed by measuring ferritin concentrations in the
cells. Six replicates of each Fe bioavailability measure-
ment were performed. In terms of materials for the
study, Caco-2 cells were obtained from the American
Type Culture Collection (Rockville, MD) at passage 17
and used in experiments at passage 29. Cells were
seeded at densities of 50,000 cells/cm2 in collagen-
treated 6 well plates (Costar Corp., Cambridge, MA).
The integrity of the monolayer was verified by optical
microscopy. The cells were cultured at 37°C in an incu-
bator with 5% CO2 and 95% air atmosphere at constant
humidity, and the medium was changed every 48 h.
The cells were maintained in Dulbecco’s modified Eagle
medium plus 1% antibiotic/antimycotic solution, 25
mmol/L HEPES, and 10% fetal bovine serum. 48 h prior
the experiment, the growth medium was removed from
culture wells, the cell layer was washed, and the growth
medium was replaced with minimum essential media
(MEM) at pH 7.0. The MEM was supplemented with 10
mmol/L PIPES, 1% antibiotic/antimycotic solution, 4 mg/
L hydrocortisone, 5 mg/L insulin, 5 μg/L selenium, 34
μg/L triiodothyronine, and 20 μg/L epidermal growth fac-
tor. This enriched MEM contained less than 80 μg Fe/L.
All ingredients and supplements for cell culture media
were obtained from GIBCO (Rockville, MD). The cells
were used in the Fe uptake experiment at 13 days post
seeding. In these conditions, the amount of cell protein
measured in each well was highly consistent between
wells. On experiment day, 1.5 mL of the digested sample
was added to the insert’s upper chamber and incubated
for 2 h. Then, inserts were removed and 1 mL of MEM
was added. Cell cultures were incubated for 22 h at 37°C.
It was previously shown that intracellular ascorbic acid
status might influence ferritin formation (i.e. cellular Fe
uptake), and Fe related transporters and enzyme expres-
sion in Caco-2 cells [23,24,34]. In the current study,
samples were not added with ascorbic acid when Fe bio-




TEHarvesting of caco-2 cells for ferritin analysis
The ferritin and total protein contents analyses protocols
were previously described [19,23,24,35]. Briefly, growthmedium was removed from the culture well by aspiration
and the cells were washed twice with a solution containing
140 mmol/L NaCl, 5 mmol/L KCl, and 10 mmol/L PIPES
at pH 7.0. The cells were harvested by adding an aliquot
of deionized water and placing them in a sonicator (Lab-
Line instruments, Melrose Park, IL).
The ferritin and total protein concentrations were deter-
mined on an aliquot of the harvested cell suspension with
a one-stage sandwich immunoradiometric assay (FER-
IRON II Ferritin assay, Ramco laboratories, Houston, TX)
and a colorimetric assay (Bio-Rad DC Protein assay, Bio-
Rad, Hercules, CA), respectively. Caco-2 cells synthesize
ferritin in response to increases in intracellular Fe concen-
tration. Therefore, we used the ratio of ferritin/total pro-
tein (expressed as ng ferritin/mg protein) as an index of
the cellular Fe-uptake. IC
LEPhytate content in diets
A Dionex liquid (Dionex Corp. Sunnyvale, CA) chro-
matograph system (AS50 autosampler), equipped with
conductivity detector model ED50, and gradient pump
GS50 were used along with an IonPac AG11 guard
column and IonPac AS11 column (4×250 mm) to
quantify phytate. PeakNet 6.40 software was used to
process chromatographic data. The mobile phases
were (A) 200 mmol/L NaOH (carbonate-free) and (B)
deionized water, using a flow rate of 1 mL/min. Phy-
tate was extracted from 250 mg of dry, lyophilized diet
sample, in 10mL of a 1.25% H2SO4 solution; the extrac-
tion process was 2 h, after which the samples were centri-
fuged at 3660 g for 10 min. Subsamples were diluted 1:10
with deionized water, and 10 μL was injected and analyzed
(n=10).
Statistical analyses
Results were analyzed by ANOVA using the general linear
models procedure of SAS software (SAS Institute Inc. Cary,
NC). Differences between treatments were compared by
Tukey’s test were considered statisticant at P < 0.050.
Values in the text are means ± SEM.
Results
Hemoglobin (Hb), Hb Fe and Hb maintenance efficiency
(HME)
No significant differences were measured in body weights
between treatment groups (P > 0.05). However, as from
day 21 of the study, hemoglobin (Hb) concentrations were
higher (P < 0.05) in the "High" group than in the "Low"
group. In addition, as from day 14, Hb-Fe values were
higher in the "High" group than in the "Low" group; the in-
crease in total body Hb-Fe from the beginning of the study
to the end of the 6th wk was significantly greater in the




Table 3 Liver ferritin protein and liver iron1





"High + Fe" 650±18a 64.3±3.8a
"Low + Fe" 645±22a 39.6±2.3c
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ferences in HME (P < 0.05) were measured between the
"High" group and "Low" group on day 21 (P < 0.05). Also,
significant differences in HME (P < 0.05) were measured
between the "High + Fe" and "Low + Fe" groups on days
28 and 42 (P < 0.05, Table 2)."High" 435±13b 52.2±3.1b
"Low" 355±10c 43.3±2.5c
a,b,cWithin a column and for each parameter (i.e. liver ferritin or liver Fe),
treatment group means without a common letter differ, P< 0.05 (values are
mean±SEM, n=10).
1Atomic mass for iron is 55.8 g/mol.
2Liver tissue iron concentrations analysis is described in the materials and
methods section.
LE
Ferritin and iron in the liver
Avian ferritins corresponded to a weight of approxi-
mately 470 to 500 kDa [23,24,32,33,36]. Liver Fe and
ferritin concentrations were higher in the "High" group
than in the "Low" group (n=10, P < 0.05, Table 3).Gene expression of iron transporters (DMT-1, Ferroportin)
and iron reductase (DcytB) in the duodenum
Gene expression analysis of duodenal DMT-1, Ferroportin
and DcytB, with results reported relative to 18S rRNA,
revealed greater mRNA levels for DMT1, DcytB and Fer-
roportin in the "Low" group compared to the "High" group
(mean±SEM) (n=10, P < 0.05, Figure 2).Caco-2 cell ferritin protein formation
An in vitro digestion/Caco-2 cell culture model was used
to evaluate Fe bioavailability from the tested maize only
and maize based diets by measuring ferritin formation in
the cells (ie. a measure of cell Fe uptake) following expos-
ure to digests of the samples. The amount of bioavailable
iron in vitro was significantly higher (P < 0.05) in the
"High" and "High + Fe" diets than in the "Low" and "Low +
Fe" diets (mean±SEM) (n=6, P < 0.05, Table 4).
TE
Table 2 Hemoglobin (Hb, g/L), Total body Hb-Fe content (mg
chicken fed the tested diets from d 0 to d 422
Treatment3 Day 0 Day 7 Day 14
"High + Fe" Hb 92a±9.0 88a±5.0 104a ±11
Hb Fe 1.02a ±0.1 2.52a±0.2 4.35a ±0.4
HME - 22.7b ±2.9 22.5bc ±2
"Low + Fe" Hb 92a±9.0 86a±8.0 100a ±13
Hb Fe 1.02a ±0.1 2.30a±0.2 4.28a ±0.3
HME - 18.5b ±2.4 19.2c±2.5
"High" Hb 92a±9.0 88a±6.0 76b ±3.0
Hb Fe 1.02a ±0.1 2.37a±0.1 3.04b ±0.2
HME - 58.4a ±7.6 37.8a ±4.9
"Low" Hb 92a±9.0 82a±5.0 70b ±3.0
Hb Fe 1.02a ±0.1 2.21a±0.1 2.54c ±0.2
HME - 52.1a ±6.7 29.7ab±3.8
a,b,cWithin a column and for each parameter (i.e. Hb, Hb Fe, HME), treatment group
1Calculations are described in the materials and methods section.
2Values are means±SEM, n=10.
3The experimental diets are described in the materials and methods section.
RE
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ACPhytate concentration in the diet samples
No significant differences in phytate concentration (IP6)




Maize is an important component of the human food
supply, especially in Eastern and Southern Africa, the
Caribbean, and the Andean region of South America [1].
In these regions where dietary Fe deficiency and anemia
are common and are a critical health concern, maize is
often a component of every meal [1,37-40]. Hence, in-
creasing Fe bioavailability in maize has potential to alle-
viate dietary Fe deficiency.
Biofortification is the process of enriching the nutrient
quality of staple food crops via plant breeding [38,40], as
a nutritional agricultural intervention it can provide a
D 
AR) and hemoglobin maintenance efficiency1 (HME, %) in
Day 21 Day 28 Day 35 Day 42
102a ±6.0 102a ±5.0 97a ±13 97a ±7.0
5.80a ±0.4 8.35a ±0.6 9.62a ±0.6 16.49a ±0.7
.9 19.8bc±2.5 20.1b ±2.6 15.8b ±2.0 20.2b ±2.6
94ab ±14 94ab ±6.0 88a ±6.0 87a ±3.0
5.53a ±0.4 7.72a ±0.5 8.84ab±0.6 14.52ab±0.7
15.4c ±2.0 14.4c ±1.9 11.3bc±1.5 13.8c ±1.7
81b ±3.0 81b ±4.0 82a ±7.0 82ab ±9.0
4.72b ±0.2 6.30b ±0.4 8.07b ±0.5 13.79b ±1.0
40.3a ±5.2 37.7a ±4.9 35.3a ±4.6 44.9a ±5.8
66c ±7.0 66c ±5.0 68b ±4.0 67b ±8.0
3.41c ±0.2 4.62c ±0.3 6.29c ±0.4 10.73c ±0.6
28.0b ±3.6 27.1ab ±3.5 27.7a ±3.6 35.8a ±4.6
means without a common letter differ, P < 0.05.
Figure 2 Duodenum mRNA expression of DMT1, divalent metal transporter 1; DcytB, duodenal cytochrome b reductase; and
ferroportin in chickens at the age 6 weeks. Changes in mRNA expression are shown relative to expression of 18S rRNA in arbitrary units (AU).
Values are means ± SEM, n = 10, P < 0.05.





Esustainable source of micronutrients to at risk popula-
tions [41]. Iron biofortifcation and bioavailability from
plant foods is influenced by many factors, especially
polyphenols and phytic acid [42]. Iron biofortification
can be done via enhancement of concentration and or
bioavailability, and recent studies indicate that both
factors have a genetic basis but are also greatly influ-
enced by environment and genotype by environment
interactions [43,44]. Given the generally low Fe bio-
availability in staple crops, enhancing the bioavailable
fraction of Fe rather than merely increasing the total
concentration may represent an improved path for Fe
biofortification [8,9,44,45]. Additionally, the correlation
between bioavailable-Fe and total-Fe is not always robust
while both traits may have similar genetic complexity [9].
AC
TETable 4 Ferritin concentrations in Caco-2 cells exposed to sam
concentrations in samples of maize only and maize-based die
Tested sample Caco-2 Cell Ferritin2, ng/mg of
High Fe maize only 22.51±0.9c
Low Fe maize only 13.40 ±0.6d
"High + Fe" diet 74.36 ±1.6a
"Low + Fe" diet 56.89 ±1.1b
"High" diet 6.55 ±0.5e
"Low" Diet 1.31 ±0.4f
1Values are means ± SEM, n = 6.
a,b,c,d,e,f Within a column (ferritin or Fe concentrations), means without a common le
2Caco-2 bioassay procedures and preparation of the digested samples are describe
3Dietary iron concentrations analysis is described in the materials and methods sec
RE
TRCrop improvement via conventional breeding can pro-
duce vast numbers of varieties [46]. Only a fraction of
these genetically distinct individuals will have the desired
gain in quality to justify being released as a new variety.
The selection process is a key issue. One option could
be the target of selection in order to biofortify maize.
Hence, Fe concentration is an obvious choice, as its
evaluation is amenable to high-throughput screening
methods [47]. For maize and wheat, Fe concentration is
not well correlated with Fe bioavailability, while these
traits are correlated in beans [9,23,24].
The mechanisms that modulate Fe bioavailability are
unclear, therefore, estimating Fe bioavailability is import-
ant. We employed the Caco-2 bioassay as part of a re-
cursive process to create maize varieties with different
D ples of maize only and maize-based diet digests; and Fe
t digests1







tter differ, P < 0.05.
d in the materials and methods section.
tion.
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was used to evaluate 145 members of a maize mapping
population, where neither Fe concentration nor phytate
levels were well correlated with bioavailable-Fe [9]. Also,
molecular genetic markers were used to evaluate nearly
700 genetically distinct individuals from our breeding
program in order to create the 4 varieties that were
selected to differ in bioavailable-Fe. Molecular breeding
approaches with these 4 inbred varieties were used to
create the 2 hybrids evaluated in this study and our pre-
liminary study [8].
The observation that bioavailable-Fe was being modu-
lated through the course of our breeding strategy needed
verification beyond the Caco-2 bioassay. This assay also
indicated that Fe bioavailability could be reliably modi-
fied across several years in NY and other sites in North
America [9]. The current results demonstrate that Caco-
2/QTL approach can be used to enhance maize Fe bio-
availability. Also, if adequate mapping populations are
available, this approach can be extended to other crops.
In this study the maize lines were grown under standard
agronomic conditions on a research farm, similar to other
varieties of maize grown that summer. This demonstrates
that the High and Low Fe bioavailability varieties can be
grown using production scale agriculture. Current study
followed a previous study, where similar results were
obtained with smaller amounts of maize (~30 kg), where
all plants were hand pollinated and harvested [8]. Thus we
have demonstrated that the nutritional differential between
the High and Low Fe bioavailability varieties can be created
and maintained in consecutive years using different field
practices. This benefit was confirmed as birds receiving the
High-Fe bioavailability maize diets had improved Fe status
as their liver Fe and ferritin concentrations (Table 3), and
body Hb-Fe (Table 2) were higher (P < 0.05) than birds re-
ceiving the Low-Fe bioavailability maize diets. The low-Fe
bioavailability maize-fed birds had elevated expression of
DMT1, DcytB and Ferroportin, which indicates adaptation
to the low Fe bioavailability (Figure 2).
Iron biofortification of crops can be accomplished via
an increase in concentration or an increase in bioavail-
ability. Either way, the net result is that more Fe is deliv-
ered for absorption. Increased Fe concentrations in
beans [24,26] and rice [38,50] have a beneficial effect on
the Fe status in vivo; in a human study [50] Fe-
biofortified rice improved Fe stores in Fe-deficient (not
anemic) women, even though Fe concentrations in the
rice were low (3.2 μg/g and 0.57 μg/g for the high Fe
and control rice, respectively). Recently, the effects of
high-Fe (71 μg/g) and standard-Fe (49 μg/g) red mottled
Andean beans, on Fe status of chickens were investi-
gated. Final body Hb-Fe contents were different between
the standard (12.58±1.0 mg) and high Fe (15.04 ± 0.65 mg)




TEexpression were higher and liver ferritin was lower (P <
0.05) in the standard group vs. the biofortified group, indi-
cating a physiological effort to compensate for lower diet-
ary-Fe. In vitro analysis showed lower Fe bioavailability in
cells exposed to standard bean based diet. It was con-
cluded that the higher Fe beans provided more
bioavailable-Fe than standard beans [24]. These studies
showed that the higher Fe concentration improved Fe sta-
tus, as no difference in percent bioavailability was appar-
ent. However, in the present study, Fe concentration was
similar yet the amount that was bioavailable from the
High-Fe bioavailability maize was higher.
Many cereal grains as maize are rich with phytate that
may decrease mineral bioavailability [8,9,51-53]. Our
study suggests that it is possible to counteract the Fe ab-
sorption inhibitory effect of phytate and possibly other
inhibitors by increasing Fe bioavailability (not necessarily
concentration). This knowledge is vital for developing
plant breeding strategies as part of the continuing battle
with dietary Fe deficiency.
Iron deficiency is a worldwide, endemic public health
problem. Food system-based interventions such as bio-
fortification are a practical and sustainable solution for
at risk populations [7]. An efficacy trial comparing bio-
fortified and standard maize in human populations is
now warranted.
Conclusions
Based on the data shown here, we conclude that the
enhanced bioavailable-Fe maize we have generated via a
molecular plant breeding strategy is a promising vehicle
for alleviating Fe deficiency in human populations where
maize is a major dietary staple.
The results presented in this study show that breeding
can improve the Fe quality in maize. These findings dem-
onstrate the potential for Fe biofortification in maize.
Endnote
aMention of a trademark, proprietary product or vendor
does not constitute a guarantee or warranty of the product
by the United states Department of Agriculture and does
not imply its approval to the exclusion of other products
or vendors that may also be suitable.
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